CC
PFE icon

Curian Capital’s Pfizer PFE Stock Holding History

Curian Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-285,353
Closed -$8.74M – 277
2015
Q4 		$8.74M Sell
285,353
-489,007
-63% -$15.4M 0.65% 25
2015
Q3 		$23.1M Sell
774,360
-326,701
-30% -$10.5M 0.62% 26
2015
Q2 		$35M Buy
1,101,061
+38,091
+4% +$1.24M 0.59% 32
2015
Q1 		$35.1M Buy
1,062,970
+19,931
+2% +$634K 0.59% 34
2014
Q4 		$30.8M Sell
1,043,039
-5,496
-0.5% -$158K 0.52% 39
2014
Q3 		$29.4M Buy
1,048,535
+42,573
+4% +$1.19M 0.52% 38
2014
Q2 		$28.3M Buy
1,005,962
+33,343
+3% +$950K 0.5% 39
2014
Q1 		$29.6M Buy
972,619
+463,816
+91% +$13.8M 0.53% 35
2013
Q4 		$14.8M Buy
508,803
+42,855
+9% +$1.25M 0.26% 87
2013
Q3 		$12.7M Buy
465,948
+48,766
+12% +$1.33M 0.23% 86
2013
Q2 		$11.1M Buy
+417,182
New +$11.5M 0.2% 93

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Curian Capital's PFE Position: Q1 2016 in Review

Curian Capital sold out of Pfizer (PFE) in Q1 2016, closing a stake of 285,353 shares — an estimated $8.74M sold.

Curian Capital first reported a position in PFE in Q2 2013 and held it in 11 quarters. The position peaked at $35.1M in Q1 2015. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

  • Curian Capital reported no remaining Pfizer position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 285,353 Pfizer shares in Q1 2016, an estimated $8.74M.
  • Curian Capital first reported a position in Pfizer in Q2 2013 and held it in 11 quarters.
  • Curian Capital's Pfizer position peaked at $35.1M in Q1 2015.
  • 1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.